Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Smith

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Molecular and Cellular Biology|November 30, 2005
Human TopBP1 ensures genome integrity during normal S phaseJa-Eun Kim, Sarah A McAvoy, David I Smith, et al.
Oncogene|February 28, 2003
Common fragile sites are preferential targets for HPV16 integrations in cervical tumorsErik C Thorland, Shannon L Myers, Bobbie S Gostout, et al.
Journal of the American Academy of Dermatology|April 25, 2006
Efalizumab-induced subacute cutaneous lupus erythematosusDanette D Bentley, Julia E Graves, David I Smith, et al.
The Australian and New Zealand Journal of Psychiatry|December 21, 2014
Mental illness and housing outcomes among a sample of homeless men in an Australian urban centreBridget Spicer, David I Smith, Elizabeth Conroy, et al.
Insects|March 28, 2023
Seasonal Phenology and Climate Associated Feeding Activity of Introduced <i>Marchalina hellenica</i> in Southeast AustraliaDuncan D Jaroslow, John P Cunningham, David I Smith, et al.
Archives of Dermatology|September 21, 2005
0.1% tacrolimus ointment in the treatment of discoid lupus erythematosusMichael P Heffernan, Michael M Nelson, David I Smith, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2008
DNA microchips to identify molecular signatures in cervical cancersYick Fu Wong, Tony K H Chung, Vivian W Wang, et al.
Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Off-label uses of biologic agents in dermatology: a 2006 updateMary Jo J Kerns, Julia E Graves, David I Smith, et al.
Oncogene|January 30, 2003
Characterization of the common fragile site FRA9E and its potential role in ovarian cancerGwen Callahan, Stacy R Denison, Leslie A Phillips, et al.
Genes, Chromosomes & Cancer|November 17, 2007
Disabled-1 is a large common fragile site gene, inactivated in multiple cancersSarah McAvoy, Yu Zhu, Damon S Perez, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Molecular and Cellular Biology|November 30, 2005
Human TopBP1 ensures genome integrity during normal S phaseJa-Eun Kim, Sarah A McAvoy, David I Smith, et al.
Oncogene|February 28, 2003
Common fragile sites are preferential targets for HPV16 integrations in cervical tumorsErik C Thorland, Shannon L Myers, Bobbie S Gostout, et al.
Journal of the American Academy of Dermatology|April 25, 2006
Efalizumab-induced subacute cutaneous lupus erythematosusDanette D Bentley, Julia E Graves, David I Smith, et al.
The Australian and New Zealand Journal of Psychiatry|December 21, 2014
Mental illness and housing outcomes among a sample of homeless men in an Australian urban centreBridget Spicer, David I Smith, Elizabeth Conroy, et al.
Insects|March 28, 2023
Seasonal Phenology and Climate Associated Feeding Activity of Introduced <i>Marchalina hellenica</i> in Southeast AustraliaDuncan D Jaroslow, John P Cunningham, David I Smith, et al.
Archives of Dermatology|September 21, 2005
0.1% tacrolimus ointment in the treatment of discoid lupus erythematosusMichael P Heffernan, Michael M Nelson, David I Smith, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2008
DNA microchips to identify molecular signatures in cervical cancersYick Fu Wong, Tony K H Chung, Vivian W Wang, et al.
Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Off-label uses of biologic agents in dermatology: a 2006 updateMary Jo J Kerns, Julia E Graves, David I Smith, et al.
Oncogene|January 30, 2003
Characterization of the common fragile site FRA9E and its potential role in ovarian cancerGwen Callahan, Stacy R Denison, Leslie A Phillips, et al.
Genes, Chromosomes & Cancer|November 17, 2007
Disabled-1 is a large common fragile site gene, inactivated in multiple cancersSarah McAvoy, Yu Zhu, Damon S Perez, et al.
Pageof 11